The determination of release from isolation of COVID-19 patients requires ultra-high sensitivity nucleic acid test technology - 19/01/21
Doi : 10.1016/j.jinf.2020.06.075
Wanqiu Huang 1, a, Dachuan Lin 1, b, Cuini Wang 1, a, Chaohui Bao a, Zhaoqi Zhang d, Xinchun Chen b, c, Zheng Zhang c, ⁎ 
, Jian Huang a, ⁎
, Jian Huang a, ⁎ a Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Centre for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, 200240, China
b Guangdong Key Laboratory of Regional Immunity and Diseases, Department of Pathology Biology, School of Medicine, Shenzhen University, Shenzhen, 518060, China
c Institute of Hepatology, National clinical research center for infectious diseases, Guangdong Key Lab for Diagnosis &Treatment of Emerging Infectious Diseases, Shenzhen Third People's Hospital, Southern University of Science and Technology, Shenzhen, 518112, China
d Department of General Surgery, Shanghai Jiao Tong University Affiliated First People's Hospital, Shanghai, 200080, China
⁎Corresponding authors.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Keywords : SARS-CoV-2, COVID-19, Nucleic acid detection, False negative, nestRPA
Le texte complet de cet article est disponible en PDF.
Plan
© 2020
The British Infection Association. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 82 - N° 1
P. 159-198 - janvier 2021 Retour au numéro
Article précédent
- Insufficient evidence to advise a single dose of doxycycline to prevent Lyme disease from an Ixodes tick bite.
- Daniel J. Cameron, Elizabeth Louise Maloney
- Letter in response to article in journal of infection: “Cardiovascular complications in COVID-19: A systematic review and meta-analysis”
- Dimitrios Giannis, Ioannis A. Ziogas
Bienvenue sur EM-consulte, la référence des professionnels de santé.